We also explored the relationship between FOSL2 expression and clinical pathological factors in 63 PDAC patients and found that higher FOSL2 expression was positively correlated with high tumour grade (P = 0.044) but had no association with other clinical characteristics (Supplementary Table S5). This evidence concerns the gene FOSL2 and neoplasm.